Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Category: Conferences
-
This is just a quick reminder of two upcoming conferences from ACI that should be of interest to Orange Book Blog readers: "Paragraph IV Disputes" and the "3rd Annual In-House Counsel Forum on Pharmaceutical Antitrust." "Paragraph IV Disputes," to be held April 23-24 in New York, will offer "expert insights on Hatch-Waxman litigation strategies for…
-
American Conference Institute has announced that its first ever conference devoted entirely to Hatch-Waxman litigation will take place April 23-24, 2007, at the Sheraton New York Hotel and Towers in New York City. The conference promises “expert insights on Hatch-Waxman litigation strategies for brand names and generics.” Speakers will include leading patent litigators who specialize in…
-
American Conference Institute has announced that it will hold the third installment of its “unique antitrust event, designed specifically for the entire pharmaceutical industry…brand names and generics alike," May 15-16, 2007, at the Warwick New York Hotel in New York City. The conference will feature addresses by FTC Chairman Deborah Platt Majoras, Assistant Attorney General…
-
Law Seminars International has announced that it will hold “a comprehensive two-day conference on licensing, life-cycle management, and M&A issues in the field of pharmaceutical antitrust,” April 26-27, 2007, at the Capital Hilton in Washington, D.C. The conference will feature a special address by FTC Commissioner J. Thomas Rosch and presentations by six other federal…
-
International Quality & Productivity Center has announced that its "Pharmaceutical & Biotech Patent Litigation Strategies 2007" conference will be held March 27-28, 2007, in London, England. The conference will cover the evolving trends in both Europe and the United States. Speakers include in-house counsel from major pharmaceutical companies as well as outside counsel who specialize…
-
American Conference Institute has announced that its third FDA Boot Camp will be taking place March 26-27, 2007, in New York, New York. According to ACI, the inaugural FDA Boot Camp conference, held in New York last March, was sold out, as was this past September’s FDA Boot Camp in Chicago. Designed for product liability…
-
Law Seminars International will present its “Biotechnology 2007: Key Legal and Business Developments” conference January 28-29, 2007, in San Francisco. Speakers include outside and inside counsel, biotechnology industry executives, and financiers. The first day of the conference will focus on legal developments important to the biotechnology industry, while the second day will focus on business and financing issues. Specific…
-
American Conference Institute has announced that its 3rd National Conference on Life Sciences IP Due Diligence will take place in San Francisco on January 22-23, 2007. This event features leading IP practitioners and experienced in–house counsel from the West Coast who will address some of the unique challenges facing companies when conducting IP due diligence,…
-
American Conference Institute will present its "Pharma/Biotech Industry Forum on Patent Portfolio Management" conference in New York City on February 27-28, 2007. Many commercialized drugs are born in universities. Pharma/biotech companies face budget constraints, so they turn to universities to come up with early-stage drugs that the companies then refine. But such tech transfer deals…
-
ACI’s 7th annual Maximizing Pharmaceutical Patent Life Cycles conference will take place October 23-24, 2006, at the Helmsley Park Lane hotel in New York City. This should be an excellent meeting, with the following presentations: Striking a Balance: Reconciling the Needs and Interests of Brand Name and Generic Pharmaceutical Companies With Public Policy From Product…
